Actively Recruiting
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Led by M.D. Anderson Cancer Center · Updated on 2025-12-18
250
Participants Needed
1
Research Sites
619 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
CONDITIONS
Official Title
Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with peripheral lung tumors (primary or metastatic) that have been or will be ablated via robotic bronchoscopy.
You will not qualify if you...
- Patients with planned bronchoscopic ablations of peripheral lung tumors that were aborted for technical reasons (ablation was not completed).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
R
Roberto F Casal, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here